A randomized phase <scp>II</scp> study of <scp>SM</scp> ‐88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond-Reference-Cited by-同舟云学术

A randomized phase II study of SM ‐88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond

Published:2022-05-02 Issue:22 Volume:11 Page:4169-4181
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Noel Marcus S.¹^ORCID,Kim Semmie²,Hartley Marion L.³^ORCID,Wong Steve⁴,Picozzi Vincent J.⁵,Staszewski Harry⁶,Kim Dae Won⁷,Van Tornout Jan M.²,Philip Philip Agop⁸⁹,Chung Vincent¹⁰,Ocean Allyson J.¹¹,Wang‐Gillam Andrea¹²

Affiliation:

1. Georgetown Lombardi Comprehensive Cancer Center Washington District of Columbia USA

2. TYME Technologies Inc. Bedminster New Jersey USA

3. The Ruesch Center for the Cure of Gastrointestinal Cancers Washington District of Columbia USA

4. Sarcoma Oncology Research Center Santa Monica California USA

5. Virginia Mason Hospital and Medical Center Seattle Washington USA

6. Mather Hospital Port Jefferson New York USA

7. The University of Texas MD Anderson Cancer Center Houston Texas USA

8. Karmanos Cancer Center Wayne State University Michigan Detroit USA

9. SWOG Farmington Hills Michigan USA

10. City of Hope Duarte California USA

11. Weill Cornell Medicine New York‐Presbyterian Hospital New York New York USA

12. Washington University School of Medicine in St. Louis St. Louis Missouri USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4768

Reference51 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. HowladerN NooneAM KrapchoM et al. eds.SEER Cancer Statistics Review 1975–2016.National Cancer Institute. Bethesda MD based on November 2018 SEER data submission posted to the SEER Web site April 2019. Accessed November 9 2021.https://seer.cancer.gov/csr/1975_2016

3. Cancer Statistics, 2021

4. Cancer statistics, 2020

5. Estimated Projection of US Cancer Incidence and Death to 2040

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of cytotoxic effect of siphonochilone from African ginger: an in vitro analysis;Environmental Toxicology;2024-05-14

2. Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma;Journal of Cancer;2024

3. Efficacy and safety of abemaciclib alone and withPI3K/mTORinhibitorLY3023414or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial;Cancer Medicine;2023-10

4. Seamless phase II/III design: a useful strategy to reduce the sample size for dose optimization;JNCI: Journal of the National Cancer Institute;2023-05-27

5. Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?;ESMO Open;2022-12